Diketopiperazine (GV)

General Information


DRACP ID  DRACP02962

Peptide Name   Diketopiperazine (GV)

Sequence  GV

Sequence Length  2

UniProt ID  Not available

PubChem CID  736942 

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma 12.58 ± 1.23% Inhibition=10 µM ; 23.46 ± 2.04% Inhibition=100 µM MTT assay 48 h 1
HT-29 Colon adenocarcinoma Carcinoma 6.87 ± 0.67% Inhibition=10 µM; 23.90 ± 2.25% Inhibition=100 µM MTT assay 48 h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma 7.00 ± 0.56% Inhibition=10 µM; 21.19 ± 2.04% Inhibition=100 µM MTT assay 48 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02962

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  NCB: Gly1<--->Val2

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C7H14N2O3

Absent amino acids  ACDEFHIKLMNPQRSTWY

Common amino acids  GV

Mass  19222

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  1

Net charge  0

Boman Index  498

Hydrophobicity  190

Aliphatic Index  145

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18436344

Title  The synthesis and anticancer activity of selected diketopiperazines

Doi 10.1016/j.peptides.2008.03.010

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_18854

DRACP is developed by Dr.Zheng's team.